These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28630061)

  • 1. Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.
    Parashar K; Kopping E; Frank D; Sampath V; Thanassi DG; Carpino N
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phagocytes from Mice Lacking the Sts Phosphatases Have an Enhanced Antifungal Response to Candida albicans.
    Frank D; Naseem S; Russo GL; Li C; Parashar K; Konopka JB; Carpino N
    mBio; 2018 Jul; 9(4):. PubMed ID: 30018105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for the Sts phosphatases in negatively regulating IFNγ-mediated production of nitric oxide in monocytes.
    Parashar K; Carpino N
    Immun Inflamm Dis; 2020 Dec; 8(4):523-533. PubMed ID: 32841534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
    Kurtz SL; Bosio CM; De Pascalis R; Elkins KL
    Microbes Infect; 2016 Dec; 18(12):758-767. PubMed ID: 27475899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W
    Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
    Cole LE; Shirey KA; Barry E; Santiago A; Rallabhandi P; Elkins KL; Puche AC; Michalek SM; Vogel SN
    Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Selenoproteins Restrict Intracellular Replication of
    Markley RL; Restori KH; Katkere B; Sumner SE; Nicol MJ; Tyryshkina A; Nettleford SK; Williamson DR; Place DE; Dewan KK; Shay AE; Carlson BA; Girirajan S; Prabhu KS; Kirimanjeswara GS
    Front Immunol; 2021; 12():701341. PubMed ID: 34777335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.
    Zhang P; Katz J; Michalek SM
    Mol Immunol; 2009 Feb; 46(4):677-87. PubMed ID: 18929413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
    Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
    J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis.
    Chen W; KuoLee R; Shen H; Conlan JW
    Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity.
    Kurtz SL; De Pascalis R; Meierovics AI; Elkins KL
    PLoS One; 2021; 16(3):e0249142. PubMed ID: 33760886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis.
    Chen W; KuoLee R; Shen H; Bùsa M; Conlan JW
    Microb Pathog; 2004 Oct; 37(4):185-91. PubMed ID: 15458779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aged mice display an altered pulmonary host response to Francisella tularensis live vaccine strain (LVS) infections.
    Mares CA; Ojeda SS; Li Q; Morris EG; Coalson JJ; Teale JM
    Exp Gerontol; 2010 Feb; 45(2):91-6. PubMed ID: 19825409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse myeloid and lymphoid cell subpopulations produce gamma interferon during early innate immune responses to Francisella tularensis live vaccine strain.
    De Pascalis R; Taylor BC; Elkins KL
    Infect Immun; 2008 Sep; 76(9):4311-21. PubMed ID: 18573901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
    Yee D; Rhinehart-Jones TR; Elkins KL
    J Immunol; 1996 Dec; 157(11):5042-8. PubMed ID: 8943413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection from systemic Candida albicans infection by inactivation of the Sts phosphatases.
    Naseem S; Frank D; Konopka JB; Carpino N
    Infect Immun; 2015 Feb; 83(2):637-45. PubMed ID: 25422266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.